» Articles » PMID: 27092520

Comparison of Anthropometric and Atherogenic Indices As Screening Tools of Metabolic Syndrome in the Kazakh Adult Population in Xinjiang

Overview
Publisher MDPI
Date 2016 Apr 20
PMID 27092520
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the screening ability of various anthropometric and atherogenic indices for Metabolic syndrome (MetS) using three common criteria and to evaluate the validity of suitable parameters in combination for the screening of MetS among a Kazakh population in Xinjiang.

Methods: A total of 3752 individuals were selected using the stratified cluster random sampling method from nomadic Kazakhs (≥18 years old) in Xinyuan county, Xinjiang, China, which is approximately 4407 km away from the capital Beijing. MetS was defined by the International Diabetes Federation (IDF), National Cholesterol Education Program Adult Treatment Panel III (ATP III) and Joint Interim Statement (JIS) criteria. The receiver operating characteristic curve (ROC) was used to compare the area under the ROC curve (AUC) of each index. The sensitivity, specificity, Youden's index and cut-offs of each index for the screening of MetS were calculated.

Results: According to the IDF, ATP III and JIS criteria, 18.61%, 10.51%, and 24.83% of males and 23.25%, 14.88%, and 25.33% of females had MetS. According to the IDF criteria, the waist-to-height ratio (WHtR) was the index that most accurately identified individuals with and without MetS both in males (AUC = 0.872) and females (AUC = 0.804), with the optimal cut-offs of 0.53 and 0.52, respectively. According to both the ATP III and JIS criteria, the lipid accumulation product (LAP) was the best index to discriminate between individuals with and without MetS in males (AUC = 0.856 and 0.816, respectively) and females (AUC = 0.832 and 0.788, respectively), with optimal cut-offs of 41.21 and 34.76 in males and 28.16 and 26.49 in females, respectively. On the basis of the IDF standard, Youden's indices of WHtR and LAP serial tests for the screening of MetS were 0.590 and 0.455 in males and females, respectively, and those of WHtR and LAP parallel tests were 0.608 and 0.479, accordingly.

Conclusion: According to the IDF, ATP III and JIS criteria, both the WHtR and LAP were better indices for the screening of MetS. The WHtR and LAP parallel test was the most accurate.

Citing Articles

Visceral Adiposity Index and Lipid Accumulation Product as Effective Markers of Different Obesity Phenotypes in Korean Adults: A Cross-Sectional Analysis.

Yu S, Shin K Diabetes Metab Syndr Obes. 2023; 16:495-504.

PMID: 36824322 PMC: 9942502. DOI: 10.2147/DMSO.S397043.


Association of Lipid Accumulation Product and Triglyceride-Glucose Index with Metabolic Syndrome in Young Adults: A Cross-sectional Study.

Rajendran S, Kizhakkayil Padikkal A, Mishra S, Madhavanpillai M Int J Endocrinol Metab. 2022; 20(2):e115428.

PMID: 35993037 PMC: 9375935. DOI: 10.5812/ijem-115428.


Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease.

Qin L, Rehemuding R, Ainiwaer A, Ma X World J Clin Cases. 2022; 10(7):2095-2105.

PMID: 35321188 PMC: 8895170. DOI: 10.12998/wjcc.v10.i7.2095.


Children's Lipid Accumulation Product Combining Visceral Adiposity Index is a Novel Indicator for Predicting Unhealthy Metabolic Phenotype Among Chinese Children and Adolescents.

Dong Y, Bai L, Cai R, Zhou J, Ding W Diabetes Metab Syndr Obes. 2021; 14:4579-4587.

PMID: 34848982 PMC: 8627249. DOI: 10.2147/DMSO.S337412.


Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus.

Ou Y, Lee M, Lin I, Wen W, Hsu W, Chen S Ren Fail. 2021; 43(1):1250-1258.

PMID: 34461808 PMC: 8409948. DOI: 10.1080/0886022X.2021.1969247.


References
1.
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4):683-9. DOI: 10.2337/diacare.24.4.683. View

2.
Bergman R, Stefanovski D, Buchanan T, Sumner A, Reynolds J, Sebring N . A better index of body adiposity. Obesity (Silver Spring). 2011; 19(5):1083-9. PMC: 3275633. DOI: 10.1038/oby.2011.38. View

3.
Khanam M, Qiu C, Lindeboom W, Streatfield P, Kabir Z, Wahlin A . The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One. 2011; 6(6):e20259. PMC: 3115931. DOI: 10.1371/journal.pone.0020259. View

4.
Guo H, Guo S, Zhang J, Ma R, Rui D, Xu S . [Study on the prevalence of metabolic syndrome among the Kazakh population in Xinjiang]. Zhonghua Liu Xing Bing Xue Za Zhi. 2010; 31(7):747-50. View

5.
Muller M, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A . Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012; 13 Suppl 2:6-13. DOI: 10.1111/j.1467-789X.2012.01033.x. View